Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Advances in the treatment of relapsing - Remitting multiple sclerosis.
Pathogenesis of immune-mediated neuropathies.
Impact of a 10-week individualized exercise program on physical function and fatigue of people with multiple sclerosis: a pilot study.
Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin.
Juvenile myoclonic epilepsy with multiple sclerosis: Is there a dual role for valproate?
The use of valproic acid and multiple sclerosis.
Multiple sclerosis update.
Health literacy association with health behaviors and health care utilization in multiple sclerosis: a cross-sectional study.
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-anchored EGFP.
Neurologic indications for therapeutic plasma exchange: 2013 update.
Regulatory B Cells in Experimental Autoimmune Encephalomyelitis (EAE).
Linear pontine trigeminal root and trigeminal nerve lesions in multiple sclerosis.
Current management of relapsing-remitting multiple sclerosis.
The major myelin-resident protein PLP is transported to myelin membranes via a transcytotic mechanism: involvement of sulfatide.
Psychiatric comorbidity in multiple sclerosis: It's not the genes.
Ecological validity of walking capacity tests in multiple sclerosis.
Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
Registers of multiple sclerosis in Denmark.
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.
Multiple sclerosis and pregnancy.
TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients.
Epigenetics and the Modulation of Neuroinflammation.
Interactions of environment and genes in multiple sclerosis.
Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.
Pages
« first
‹ previous
…
429
430
431
432
433
434
435
436
437
…
next ›
last »